BRD9 and posterior cortical atrophy: Further analysis from two independent datasets (GSE3325 and GSE35988) demonstrated that BRD9 expression progressively and significantly increased from benign and primary localized PCa to metastatic CRPC (mCRPC) tissues (Fig. 1C, D), suggesting an increasing requirement for BRD9 during progression to CPRC.